(Total Views: 440)
Posted On: 03/31/2021 9:35:21 AM
Post# of 148942
Re: ClosetInvestor #84876
How did he ignore the DSMC? By skipping the suggested look at 75% when the trial was rapidly enrolling and near completion? The DSMC should have caught the dosing issue at the 50% mark on those near the 28 day endpoint NO?
(5)
(0)Scroll down for more posts ▼
